3V49

Structure of ar lbd with activator peptide and sarm inhibitor 1


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.7 Å

wwPDB Validation 3D Report Full Report


This is version 1.4 of the entry. See complete history

Literature

Discovery of diarylhydantoins as new selective androgen receptor modulators.

Nique, F.Hebbe, S.Peixoto, C.Annoot, D.Lefrancois, J.-M.Duval, E.Michoux, L.Triballeau, N.Lemoullec, J.M.Mollat, P.Thauvin, M.Prange, T.Minet, D.Clement-Lacroix, P.Robin-Jagerschmidt, C.Fleury, D.Guedin, D.Deprez, P.

(2012) J.Med.Chem. 55: 8225-8235

  • DOI: 10.1021/jm300249m
  • Primary Citation of Related Structures:  

  • PubMed Abstract: 
  • A novel selective androgen receptor modulator scaffold has been discovered through structural modifications of hydantoin antiandrogens. Several 4-(4-hydroxyphenyl)-N-arylhydantoins displayed partial agonism with nanomolar in vitro potency in transact ...

    A novel selective androgen receptor modulator scaffold has been discovered through structural modifications of hydantoin antiandrogens. Several 4-(4-hydroxyphenyl)-N-arylhydantoins displayed partial agonism with nanomolar in vitro potency in transactivation experiments using androgen receptor (AR) transfected cells. In a standard castrated male rat model, several compounds showed good anabolic activity on levator ani muscle, dissociated from the androgenic activity on ventral prostate, after oral dosing at 30 mg/kg. (+)-4-[3,4-Dimethyl-2,5-dioxo-4-(4-hydroxyphenyl)imidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile ((+)-11b) displayed anabolic potency with a strong dissociation between levator ani muscle and ventral prostate (A(50) = 0.5 mg/kg vs 70 mg/kg). The binding modes of two compounds, including (+)-11b, within the AR ligand-binding domain have been studied by cocrystallization experiments using a coactivator-like peptide. Both compounds bound to the same site, and the overall structures of the AR were very similar.


    Organizational Affiliation

    GALAPAGOS, Parc Biocitech, 102 Avenue Gaston Roussel, 93230 Romainville, France.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Androgen receptor
A
266Homo sapiensMutation(s): 0 
Gene Names: AR (DHTR, NR3C4)
Find proteins for P10275 (Homo sapiens)
Go to Gene View: AR
Go to UniProtKB:  P10275
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetails
Androgen receptor, activator peptide
B
11Homo sapiensMutation(s): 0 
Gene Names: AR (DHTR, NR3C4)
Find proteins for P10275 (Homo sapiens)
Go to Gene View: AR
Go to UniProtKB:  P10275
Small Molecules
Ligands 2 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
PK0
Query on PK0

Download SDF File 
Download CCD File 
A
4-[(4R)-4-(4-hydroxyphenyl)-3,4-dimethyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
C19 H14 F3 N3 O3
IHPVXUVRRPAUIQ-GOSISDBHSA-N
 Ligand Interaction
SO4
Query on SO4

Download SDF File 
Download CCD File 
A
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
PK0IC50: 9.6 nM (100) BINDINGDB
PK0IC50: 9.6 nM BINDINGMOAD
PK0IC50: 9.6 nM PDBBIND
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.7 Å
  • Space Group: P 21 21 21
Unit Cell:
Length (Å)Angle (°)
a = 54.629α = 90.00
b = 67.331β = 90.00
c = 69.809γ = 90.00
Software Package:
Software NamePurpose
SHELXmodel building
ADSCdata collection
SCALAdata scaling
SHELXL-97refinement
SHELXphasing
MOSFLMdata reduction

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Revision History 

  • Version 1.0: 2012-09-05
    Type: Initial release
  • Version 1.1: 2012-12-19
    Type: Database references
  • Version 1.2: 2014-10-08
    Type: Structure summary
  • Version 1.3: 2016-08-31
    Type: Other
  • Version 1.4: 2018-01-24
    Type: Structure summary